Molecular genetic defects in endometriosis.

Area of Science:

• Oncology
• Genetics
• Gynecology

Background:

• Endometriosis proliferation is hypothesized to involve oncogene mutations or tumor suppressor gene deletions.
• Previous studies found no mutations in TP53 and RASK genes in endometriosis.
• Endometriotic deposits were shown to be monoclonal.

Purpose of the Study:

• To investigate genetic alterations in endometriosis.
• To determine if genetic alterations in endometriosis are common to endometrioid ovarian carcinoma.
• To explore the lineage of endometriotic lesions and their relationship to malignant transformation.

Main Methods:

• Analysis of loss of heterozygosity (LOH) on specific chromosomal regions (9p, 11q, 22q) in endometriotic lesions.
• Comparison of genetic alterations between adjacent endometriosis, atypical endometriosis, and endometrioid carcinoma.
• Mutation analysis of PTEN/MMAC tumor suppressor genes in different types of ovarian tumors.

Main Results:

• Loss of heterozygosity was detected in 28% of endometriotic lesions at chromosomes 9p, 11q, and 22q.
• No LOH was observed in normal endometrium.
• Common genetic alterations were identified between adjacent endometriosis and endometrioid carcinoma, suggesting a common lineage.
• Increased PTEN/MMAC gene mutations were found in endometrioid tumors but not in clear cell or serous carcinoma.

Conclusions:

• Endometriosis exhibits genetic alterations, including LOH, supporting its potential role in malignant transformation.
• Genetic evidence suggests a common origin for endometriosis and endometrioid ovarian carcinoma.
• Distinct genetic pathways may underlie the development of different types of endometrioid ovarian tumors.